InvestorTransforming businesses for long-term success.

Starbloom Capital is a venture capital firm based in New York and San Francisco, investing in breakthrough innovations in neuroAI, longevity, and deep tech. They partner with visionary founders to advance science and technology.
Online destinations
Where to find this organization online, grouped by who runs each page. A link here does not mean the organization controls it.
Pages the organization runs itself.
Starbloom Capital is an investment organization founded in 2021 by James Fickel, with offices in New York and San Francisco. The firm focuses on investing in breakthrough innovations in deep technology, particularly in the sectors of longevity biotechnology, neuroscience, and artificial intelligence. Starbloom Capital partners with founders who are advancing the frontiers of science and technology, aiming to push the boundaries of human potential. The organization is also connected to the Amaranth Foundation, which focuses on longevity and neuroscience philanthropy, complementing Starbloom's investment mission.
Starbloom Capital invests primarily in deep tech innovations, with a strong emphasis on longevity biotechnology, neuroAI, and emerging industries. The firm seeks to collaborate with visionary founders who are pushing the boundaries of science and technology to develop impactful solutions.
Starbloom Capital adds value to its portfolio companies by providing strategic guidance, access to a network of industry experts, and support in navigating the complexities of deep tech and biotech sectors. The firm leverages its expertise in longevity and neuroscience to help founders accelerate their innovations and achieve their goals.
Starbloom Capital primarily invests in early-stage companies within the biotech, AI, and longevity sectors. The firm looks for visionary founders who are pushing the boundaries of science and technology.
Founders can reach out to Starbloom Capital via email at hello@starbloom.capital. It is advisable to include a detailed pitch deck outlining the business model, market opportunity, and team background.
Starbloom Capital distinguishes itself through its focus on deep tech innovations and its strong ties to the Amaranth Foundation, which enhances its commitment to longevity and neuroscience.
The firm has a global investment focus, with a particular emphasis on opportunities in North America.
Starbloom Capital provides strategic guidance, access to a network of industry experts, and support in navigating the complexities of deep tech and biotech sectors.
Specific check sizes have not been disclosed, but the firm participates in seed and Series A rounds, indicating a range that aligns with early-stage funding.
Superscout Pro
Is this page right?Reviewed · How the research works